DZ Bank
AUPH icon

DZ Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History

DZ Bank’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Sell
596,618
-18,473
-3% -$295K 0.01% 391
2026
Q1 		$9.12M Buy
615,091
+27,735
+5% +$405K 0.01% 394
2025
Q4 		$9.37M Buy
587,356
+21,400
+4% +$303K 0.01% 388
2025
Q3 		$6.25M Hold
565,956
– – 0.01% 481
2025
Q2 		$4.79M Buy
565,956
+280,804
+98% +$2.25M ﹤0.01% 482
2025
Q1 		$2.29M Buy
+285,152
New +$2.31M ﹤0.01% 566

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DZ Bank's AUPH Position: Q2 2026 in Review

DZ Bank reduced its Aurinia Pharmaceuticals (AUPH) stake by 3% in Q2 2026, selling an estimated $295K and leaving 596,618 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #391.

DZ Bank first reported a position in AUPH in Q1 2025 and has held it in 6 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • DZ Bank held 596,618 shares of Aurinia Pharmaceuticals worth $10.1M as of Q2 2026.
  • DZ Bank sold 18,473 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $295K.
  • Aurinia Pharmaceuticals made up 0.01% of DZ Bank's portfolio in Q2 2026, its #391 holding.
  • DZ Bank first reported a position in Aurinia Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.